Shopping Cart
- Remove All
Your shopping cart is currently empty
CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $36 | In Stock | |
| 5 mg | $58 | In Stock | |
| 10 mg | $89 | In Stock | |
| 25 mg | $166 | In Stock | |
| 50 mg | $277 | In Stock | |
| 100 mg | $449 | In Stock | |
| 200 mg | $649 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $64 | In Stock |
| Description | CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). |
| In vivo | CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls.?Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration[1]. |
| Molecular Weight | 320.39 |
| Formula | C20H20N2O2 |
| Cas No. | 892711-75-0 |
| Smiles | CC(C)Oc1ccc(cc1)C(=O)Nc1cccc2ccc(C)nc12 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (156.06 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.